Dr P J Goodford (The Wellcome Research Laboratories, Beckenham, Kent) said that Dr Robinson had outlined the effects of cardiac glycosides, catecholamines, calcium ions and paired electrical stimulation upon myocardial mechanics. He had raised the possibility that their common inotropic actions might be mediated by a single physiological mechanism, although they showed different clinical and pharmacological pictures. Would he agree that this mechanism could be the increased availability of calcium to the cardiac contractile mechanism ? There was substantial experimental evidence to show that the tension developed by heart muscle was related to the tissue calcium. Fig 1 was redrawn from Lullmann & Holland's (1962) observations on spontaneously beating guinea-pig atria, and demonstrated clearly the parallelism between these quantities. Furthermore, Reuter (1967) had shown that the slow inwards electrical current during a cardiac action potential was dependent upon the extracellular calcium concentration, and he concluded that this current, which was augmented by adrenaline, was carried into the cell by calcium ions. Other catecholamines might have similar effects, and it was self-evident that an increased extracellula r calcium concentration might by itself lead to an increased availability of calcium to the contractile mechanism of the heart. There was in fact evidence (Wilbrandt & Koller 1948) that Ca++ ions might compete for cellular entry with Na+ at some site in the tissue, and Dr Goodford wondered if any observations had been reported which might support the hypothesis that the inotropic action of paired electrical stimulation was also mediated by calcium. Dr 
Drugs and Myocardial Blood Flow
The myocardium has a high rate of metabolism and a correspondingly rich blood supply. Even in the resting animal, blood flow may exceed that of fully exercised skeletal muscle, and the myocardial oxygen extraction fraction is greater than in any other tissue. The normal determinant of myocardial blood flow (MBF) is the tissue oxygen requirement, and flow is regulated by changes in coronary arteriolar tone so that the coronary sinus 02 content is kept constant.
It used to be thought that external cardiac work, the product of output and blood pressure, was a good index of myocardial 02 requirement and blood flow. Since external cardiac work can be measured with relative ease, it is unfortunate that this is not so. Oxygen requirement has been correlated with other factors such as the rate of rise of pressure (dp/dt) and the force and duration of contraction (tension time index) but the relationships are imprecise and variable.
It should be remembered that any drug used for its hamodynamic action will have a secondary effect on myocardial oxygen requirement, the direction and extent of which can only be partially predicted. Thus the effect of any new cardiovascular drug on MBF must be measured directly in the intact animal, as it should be used with caution in patients with ischwmic heart disease if it provokes a secondary rise in flow consequent on its hemodynamic and metabolic effects.
Methods for the measurement of MBF have previously been reviewed (Rees & Redding 1966) . In man, there are only two accepted methods, the nitrous oxide saturation or desaturation technique which requires coronary sinus catheterization (Eckenhoff et al. 1947) , and the radioxenon clearance technique which requires coronary artery catheterization (Ross et al. 1964 ). The opportunities to study MBF in man are therefore restricted, and most of the scientific data on the TIME J2 Rees & Redding 1966) effects of drugs on myocardial perfusion come from animal work.
Obstructive coronary artery disease is the cardiologist's main problem and three aspects of drug therapy in this condition will be considered:
(1) Drugs that relieve angina: do they act by increasing MBF or otherwise? (2) Drugs used in acute myocardial infarction: how do they affect the collateral circulation? (3) Drugs which are powerful coronary vasodilators: have they any clinical use? Drugs that Relieve Angina Glyceryl trinitrate (GTN) and propranolol are the only ones generally accepted. Nitrites have been in use for ninety years (Brunton 1867, Murrell 1879) but their mode of action remains uncertain. When GTN is given to animals in the appropriate timing and dosage to correspond with its use by patients, it can be shown to have a biphasic effect on MBF (Rees et al. 1966 ). An increase of more than 50%O is followed by a smaller but more prolonged reduction in flow.
Fig 1 shows the hamodynamic effects of GTN
0-01 mg/kg given over 1 minute to a group of 10 dogs. Mean percentage changes from control values are shown, and the response is essentially biphasic. Initially, the cardiac output rose sharply, blood pressure fell, and there were increases both in myocardial flow and in left ventricular power, or rate of work. Coronary and systemic vascular resistances were equally reduced. The 02 content of coronary sinus samples doubled, and there was a fall in 02 consumption, despite the increase in cardiac work rate. Thus, external cardiac efficiency, a measure of work done per unit 02 consumed, was increased. At three minutes, the effects were very different. The blood pressure had risen but cardiac output, tissue flow and myocardial rate of work had all fallen. Vascular resistance was back in the normal range, and oxygen consumption was further reduced, with a return to control level of external cardiac efficiency. The results at 6 and 10 minutes were similar and varied only in degree.
The effects of the drug are explained by systemic and coronary vasodilatation of equal degree, and prolonged venous pooling of blood. Regardless of other biphasic changes throughout, there was reduced myocardial oxygen consumption.
When we compare the effect of propranolol in similar experiments the effects are very different. Cardiac output, MBF and left ventricular rate of work are all reduced, and both coronary and systemic vasoconstriction occur, in contrast to the effects of GTN. The only similarity is a reduction in myocardial oxygen consumption. It has been found that GTN given after propranolol will reverse its coronary vasoconstrictor effect and raise the coronary sinus 02 content. year-old man with ischaemic heart disease. Radioxenon clearance slopes and myocardial blood flow before and after giving the drug Fig 3 shows some studies of MBF in a 45-yearold man with partial obstruction to the right coronary artery as shown in the tracing of his arteriogram. He was without angina during the investigation and when arteriography was completed the radioxenon clearance curves were obtained; the originals are shown in the figure.
With the tip of the arteriographic catheter in the mouth of the right coronary artery, a small quantity of radioxenon in solution was injected. This inert gamma emitter is highly diffusable, and on reaching the capillaries it passes rapidly out into the myocardium. It is then removed by fresh capillary blood over the succeeding few minutes and its rate of removal is a measure of MBF. This is determined by an external scintillation counter pointed at the hea-rt.
Such clearance slopes usually prove to be exponential and can be redrawn by hand or by computer. From the tj of the slope, the clearance constant (k) is calculated, and from a formula employing the Fick principle, MBF is derived in ml/min per 100 g of myocardium, in this case 61 ml/min/ 100 g. When GTN was given sublingually this rose to 71 ml/min/100 g despite a slight fall in perfusion pressure confirming that glyceryl trinitrate can increase myocardial blood flow in such patients.
Thus the common feature with these dissimilar drugs is an economy in oxygen requirement which probably explains their value in angina, when diseased vessels are already likely to be as widely dilated as possible in response to ischemia. This would account for the failure of powerful coronary vasodilator drugs which do not reduce myocardial oxygen consumption in this condition.
What effect does GTN have on MBF in patients with coronary artery disease? When Gorlin and his colleagues first studied this problem, using the N2O technique, it seemed that coronary resistance was fixed in these patients so that vasodilatation could not occur (Gorlin et al. 1959 ). This conclusion is often quoted, but the N2O method is not suitable for studying drugs of rapid action such as GTN because of the long time required for each measurement of flow. In fact, recent studies with radioxenon have shown a capacity for vasodilatation in most patients with severe ischemic heart disease (Bernstein et al. 1966 ).
If this is so, what happens to MBF when patients take GTN for angina? Such studies cannot be planned and one must take advantage of rare opportunities as they arise after coronary arteriography. changes in the ST segments of his ECG. Blood pressure and heart rate then increased slightly. In the 4th minute of angina MBF was in the normal range, 75 ml/min/100 g. The ischwmic changes in his ECG increased and 8 min after onset of his angina sublingual GTN was given. Within a minute, the pain eased, and whilst it was going, MBF was measured again, as the ischwmic changes disappeared in his ECG: it was 78 ml/min/100 g. The fact that MBF was unchanged during relief of this severe attack of angina suggests that GTN does not act by increasing MBF. mmHg, reducing perfusion pressure by twothirds. Despite this, the patient felt well, and had no recurrence of his pain, even during a short run of ventricular premature beats at 10.43 a.m. He recovered completely, with no after-effects, and it is reasonable to assume that perfusion of his ischamic myocardium was much reduced during this hypotensive attack, but was adequate in these circumstances because of a greatly reduced myocardial oxygen requirement. This is supported by Fig 6, an animal study with cardiac output and MBF measurements, in which a similar severe hypotensive reaction to a normal dose of GTN occurred. As the blood pressure fell by 60 O coronary sinus 02 content rose, indicating that the slightly reduced MBF was more than adequate. In the presence of coronary obstruction, an even greater reduction in perfusion is likely.
Drugs Used in Acute Myocardial Infarction
There is no way in man of assessing the effect of drugs on the collateral circulation. In the dog, however, the effects of drugs on the collateral circulation have been studied after tying the anterior descending artery or after wedgirg a catheter in the circumflex artery. The latter method permits myocardial infarction and collateral flow measurement without thoracotomy, and without otherwise disturbing the heart, its vessels or its nerves (Rees & Redding 1967a , 1968 . In both instances collateral flow rates are determined by injecting solutions of radioxenon (xenon 133) into the vessels within the infarct beyond the obstruction, and then measurirg their rates of clearance by an external counter.
We have found that powerful coronary vasodilator drugs have only a slight effect soon after arterial obstruction in contrast to their effect on the remainder of the coronary vasculature. Two hours after acute myocardial infarction a mean increase in collateral flow of only 11 % was noted in a group of dogs given dipyridamole (Fig 7) .
This suggests that vasodilatation in the collateral vessels is almost complete at this stage so that collateral flow rates will be expected to vary with perfusion pressure, a relationship which we have generally confirmed.
Clearance is increased slightly by vasodilators, including dipyridamole, lidoflazine, vialibran and GTN. It is increased by adrenaline, noradrenaline, mephentermine and metaraminol, all of which raise systemic pressure. It is reduced by falls in blood pressure due to cardiogenic shock, hemorrhage, propranolol, barbiturate and multiple ventricular premature systoles.
The Role of Powverful Coronary Vasodilator Drugs
There are now a number of coronary vasodilator drugs of high activity and relative specificity, all of which have proved to be disappointing in the treatment of angina. In contrast to GTN these drugs are not rapidly absorbed and cannot be conveniently given for the acute attack; they act on the arterioles and not on the diseased epicardial arteries, and they do not reduce myo- Dark bars show mean increase in collateralflow over 30 min following administration ofdipyridamole cardial oxygen consumption. It has also been suggested (Fam & McGregor 1964 ) that they divert blood from the ischemic myocardium through competitive vasodilatation in adjacent muscle, a theory with which we disagree. The failure of these drugs in angina has discouraged their trial in other aspects of ischmmic heart disease and I wish to discuss two other possibilities.
Following acute myocardial infarction survival and recovery are determined to a large extent by the development of a collateral circulation. Little is known about the rate at which this develops in man but Fulton (1965) has shown that collateral vessels may eventually enlarge greatly in patients with chronic ischvmic heart disease, and may carry the bulk of the myocardial blood supply.
In dogs we have studied the development of this collateral supply by measuring collateral flow each day after acute myocardial infarction. Serial measurements are usually unchanged for three days, but after this a progressive rise in collateral flow commences, continuing into the normal range by about the tenth day. This increase has been found to coincide with enlargement of the interarteriolar anastomoses (Rees & Redding 1 967a).
These changes, and the effects of dipyridamole on successive days, are shown in Fig 7. In the early stages the effect of the vasodilator is slight, but after twenty-four hours a progressive rise in collateral flow results from its administration which precedes the natural increase in collateral flow (Rees & Redding 1967b) . It is not yet known what effects powerful coronary vasodilators may have in patients with acute myocardial infarction, but if the same time relationships apply some benefit might be expected in the later days of recovery.
Ischxmia is the stimulus for this collateral vessel growth, but it is of interest that it can also develop in hearts without coronary disease under the stimulus of anamia (Zoll & Norman 1952 , Eckstein 1955 . Recently it has been suggested that powerful coronary vasodilator drugs may also stimulate collateral vessel growth in normal hearts (Blachrnan et al. 1964 , Schaper et al. 1965 and thus protect the animals from the effects of subsequent coronary obstruction.
These various stimuli, ischamia, anamia and drugs, promote collateral vessel growth by causing prolonged vasodilatation. Schaper (1967) has shown that the resistant increase in tangential wall stress leads to cell division in the vessel wall, thus permitting enlargement. The interesting problem is whether such collateral vessel development can be promoted in man by vasodilator drugs and, if so, whether it will offer any practical benefit. Dr B N C Prichard (Medical Unit, Uniiversity College Hospital Medlical School, London) Variation in the Modification of Cardiovascular Responses by Sympathetic Inhibitory Drugs Drugs commonly used in the treatment of hypertension achieve their effect by inhibiting cardiovascular responses that maintain blood pressure. The physiological effects of ganglion-blocking drugs, sympathetic neurone blocking drugs and methyldopa, have many features in common that are characteristic of inhibition of the sympathetic vasoconstrictor supply to blood vessels. However, the modification of cardiovascular responses in patients where blood pressure is lowered by the P adrenergic receptor blocking drug propranolol shows important differences. These differences have important clinical significance.
